Background Introduction
Procalcitonin (PCT) is a protein composed of 116 amino acids with a molecular weight of about 13 kDa. When severe bacterial, fungal and parasitic infections, sepsis and multiple organ failure occur, the level of PCT in plasma increases, which is a parameter for diagnosing and monitoring infection of bacterial inflammatory disease. At the early stage (2-3h) of systemic inflammatory reaction caused by bacterial infection, the PCT concentration can rise, reaching the peak at 12-24h after infection. The PCT concentration was in direct proportion to the severity of the infection and returned to normal after the infection disappeared. It has a high clinical value in early diagnosis of severe bacterial infection, disease risk classification, prognosis, evaluation of anti-infection efficacy, and guidance of taking antibacterial drugs.
Recommended Diagnostic Raw Materials
[Product Information]
[Product Advantages]
★High Sensitivity
★Wide Linear Range
★High detection agreement rate compared with that of products from R Company renowned internationally
[Product Performance]
On the fluorescence immunochromatography platform, PCT and antibody were paired to detect the clinical serum assigned by R Company with fluorescence test strips. The agreement rate is R ²> 98%.
On the chemiluminescence platform, antibody was paired for PCT chemiluminescence reagent to detect the clinical serum assigned by R Company renowned internationally. The agreement rate was R ²> 98%.
[Company Background]
Qingdao Henderson Biotechnology Co., Ltd, established in 2016, serves as a professional supplier of core raw materials for in vitro diagnostic reagents and is committed to providing high-quality raw materials for global in vitro diagnostic reagent production enterprises, scientific research institutions and other fields.
The company provides the following staple products: antigens, antibodies, enzymes, etc., widely used in the detection of drug, respiratory infectious diseases (A, B, COVID-19 antigen, COVID-19 antibody, COVID-19 neutralizing antibody, syncytial virus, etc.), other infectious diseases (hepatitis, AIDS, tuberculosis, etc.), markers for tumor, inflammation, myocardial markers, animal diseases detection (dog, cat diseases) and other fields.
The company, after years of development, has established several specialized laboratories and SPF experimental animal bases, a comprehensive and systematic R&D verification platform and formed a professional technical service team to provide personalized customized services and one-stop solutions.
Qingdao Henderson Biotechnology Co., Ltd is willing to build a renowned product brand for all customers with high-quality products and professional services to keep a foothold in the market with its sound competitiveness.
Limited space only allows the introduction of major products. You are welcomed to contact Qingdao Henderson Biotechnology Co., Ltd and acquire trial samples if you need more information.
Qingdao Henderson Biotechnology Co., Ltd.
Official Website: http://www.qdhenderson.com/
Tel: 0532-84670782
E-mail: info@qdhenderson.com